<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1300" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1300/" /><meta name="ncbi_pagename" content="SOX2-Related Eye Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SOX2-Related Eye Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SOX2-Related Eye Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/07/31" /><meta name="citation_author" content="Kathleen A Williamson" /><meta name="citation_author" content="David R FitzPatrick" /><meta name="citation_pmid" content="20301477" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1300/" /><meta name="citation_keywords" content="Anophthalmia-Esophageal Atresia-Genital Abnormalities (AEG) Syndrome" /><meta name="citation_keywords" content="SOX2 Anophthalmia Syndrome" /><meta name="citation_keywords" content="Transcription factor SOX-2" /><meta name="citation_keywords" content="SOX2" /><meta name="citation_keywords" content="SOX2-Related Eye Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SOX2-Related Eye Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Kathleen A Williamson" /><meta name="DC.Contributor" content="David R FitzPatrick" /><meta name="DC.Date" content="2014/07/31" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1300/" /><meta name="description" content="SOX2-related eye disorders are characterized by anophthalmia and/or microphthalmia that is usually bilateral, severe, and apparent at birth or by prenatal ultrasound examination. Other common findings include brain malformations, esophageal atresia, cryptorchidism and/or micropenis in males, and hypogonadotropic hypogonadism and/or pituitary hypoplasia. Postnatal growth failure, delayed motor development, and learning disability are common." /><meta name="og:title" content="SOX2-Related Eye Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="SOX2-related eye disorders are characterized by anophthalmia and/or microphthalmia that is usually bilateral, severe, and apparent at birth or by prenatal ultrasound examination. Other common findings include brain malformations, esophageal atresia, cryptorchidism and/or micropenis in males, and hypogonadotropic hypogonadism and/or pituitary hypoplasia. Postnatal growth failure, delayed motor development, and learning disability are common." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1300/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sox2/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1300/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89B1E7E0403A510000000008230393.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1300_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1300_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sost/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hsn1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1300_"><span class="title" itemprop="name"><i>SOX2</i>-Related Eye Disorders</span></h1><p class="contrib-group"><span itemprop="author">Kathleen A Williamson</span>, PhD and <span itemprop="author">David R FitzPatrick</span>, MD, FRCP(EDIN).</p><a data-jig="ncbitoggler" href="#__NBK1300_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1300_ai__"><div class="contrib half_rhythm"><span itemprop="author">Kathleen A Williamson</span>, PhD<div class="affiliation small">MRC Human Genetics Unit<br />MRC Institute of Genetics and Molecular Medicine<br />University of Edinburgh<br />Edinburgh, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.de.mmgi@nosmailliw.yhtak" class="oemail">ku.ca.de.mmgi@nosmailliw.yhtak</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David R FitzPatrick</span>, MD, FRCP(EDIN)<div class="affiliation small">Consultant in Pediatric Genetics, MRC Human Genetics Unit<br />MRC Institute of Genetics and Molecular Medicine<br />University of Edinburgh<br />Edinburgh, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.de@kcirtapztif.divad" class="oemail">ku.ca.de@kcirtapztif.divad</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 23, 2006</span>; Last Update: <span itemprop="dateModified">July 31, 2014</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sox2.Summary" itemprop="description"><h2 id="_sox2_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>SOX2</i>-related eye disorders are characterized by anophthalmia and/or microphthalmia that is usually bilateral, severe, and apparent at birth or by prenatal ultrasound examination. Other common findings include brain malformations, esophageal atresia, cryptorchidism and/or micropenis in males, and hypogonadotropic hypogonadism and/or pituitary hypoplasia. Postnatal growth failure, delayed motor development, and learning disability are common.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>SOX2</i>-related eye disorders is established by clinical findings, <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> or molecular analysis to detect deletions of 3q27 (which includes <i>SOX2</i>), and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Molecular genetic testing identifies a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SOX2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in approximately 40% of individuals with bilateral anophthalmia/microphthalmia.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Use of optically clear expanders to stimulate growth of the orbit and periorbital tissues; special educational services for visually impaired infants and children; physiotherapy for motor impairment; special education for neurodevelopmental problems; use of melatonin for abnormal sleep patterns; antiepileptic drugs for seizure management.</p><p><i>Surveillance:</i> Annual hearing test and annual neurodevelopmental assessment until age five years; measurement of height, weight, and head circumference every three to six months during childhood.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>SOX2</i>-related eye disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, most often resulting from a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is usually small; however, if a parent of a proband has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, the risk to the sibs may be as high as 50%. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in the family is known. Fetal ultrasound examination reveals marked reduction in the size of the globes.</p></div></div><div id="sox2.GeneReview_Scope"><h2 id="_sox2_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="sox2.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1300/table/sox2.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sox2.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sox2.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>SOX2</i>-Related Eye Disorders: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_sox2.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div><i>SOX2</i> anophthalmia syndrome</div></li><li class="half_rhythm"><div>Anophthalmia-esophageal atresia-genital abnormalities (AEG) syndrome</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#sox2.Nomenclature">Nomenclature</a>.</p></div></dd></dl></div></div></div></div><div id="sox2.Diagnosis"><h2 id="_sox2_Diagnosis_">Diagnosis</h2><div id="sox2.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Diagnosis of <i>SOX2</i>-related eye disorders should be suspected in individuals with:</p><ul><li class="half_rhythm"><div>Bilateral anophthalmia and/or microphthalmia</div></li><li class="half_rhythm"><div>Unilateral anophthalmia or microphthalmia</div></li><li class="half_rhythm"><div>Cryptorchidism and/or micropenis in males</div></li><li class="half_rhythm"><div>Malformation and/or heterotopia of the mesial temporal structures of the brain, particularly the hippocampus</div></li><li class="half_rhythm"><div>Tracheoesophageal fistula and/or esophageal atresia</div></li><li class="half_rhythm"><div>Learning disability</div></li><li class="half_rhythm"><div>Delayed motor development</div></li><li class="half_rhythm"><div>Postnatal growth failure</div></li><li class="half_rhythm"><div>Hypogonadotropic hypogonadism with or without pituitary hypoplasia</div></li></ul></div><div id="sox2.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>SOX2</i>-related eye disorders <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by genetic testing to detect deletions, <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>, or pathogenic variation involving <i>SOX2</i>.</p><p><b>Cytogenetic analysis</b> includes <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> analysis and <a class="def" href="/books/n/gene/glossary/def-item/copy-number-variant/">copy number variant</a> analyses including array <a class="def" href="/books/n/gene/glossary/def-item/comparative-genomic-hybridization/">comparative genomic hybridization</a> (aCGH) and high-resolution detection of microdeletions known to occur in 15% of patients.</p><ul><li class="half_rhythm"><div>Cytogenetically visible deletions of 3q27 known to include <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>SOX2</i> have been observed [<a class="bk_pop" href="#sox2.REF.male.2002.807">Male et al 2002</a>, <a class="bk_pop" href="#sox2.REF.guichet.2004.828">Guichet et al 2004</a>, <a class="bk_pop" href="#sox2.REF.kelberman.2008.1865">Kelberman et al 2008</a>].</div></li><li class="half_rhythm"><div><i>De novo</i> apparently balanced translocations involving 3q27 have been detected in others [<a class="bk_pop" href="#sox2.REF.kurbasic.2000.239">Kurbasic et al 2000</a>], including loss of the entire <i>SOX2</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a t(3;11)(q26.3;p11.2)-associated 600-kb microdeletion [<a class="bk_pop" href="#sox2.REF.fantes.2003.461">Fantes et al 2003</a>] and a t(3;7)(q28;p21.3) associated 2.7-Mb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#sox2.REF.williamson.2006.1413">Williamson et al 2006</a>].</div></li><li class="half_rhythm"><div><i>De novo</i> microdeletions encompassing <i>SOX2</i> are relatively common disease-causing alleles [<a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>].</div></li></ul><p><b>Molecular analysis</b> (see <a class="figpopup" href="/books/NBK1300/table/sox2.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsox2Tmoleculargenetictestingusedin" rid-ob="figobsox2Tmoleculargenetictestingusedin">Table 1</a>) can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SOX2</i> is often performed first, followed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SOX2</i> and other genes of interest (see <a href="#sox2.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a></div></li></ul><div id="sox2.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>SOX2</i>-Related Eye Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1300/table/sox2.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sox2.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SOX2</i></td><td headers="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">25%-30%&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7%-10%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_sox2.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4%&#x000a0;<sup>3,&#x000a0;6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sox2.TF.1.1"><p class="no_margin">See <a href="/books/NBK1300/#sox2.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#sox2.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="sox2.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="sox2.TF.1.3"><p class="no_margin">Screening of &#x0003e;1000 individuals with severe eye malformations using a combination of scanning of the entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> for pathogenic variants, direct sequencing of the entire coding region, high-resolution <a class="def" href="/books/n/gene/glossary/def-item/copy-number-variant/">copy number variant</a> analyses, and <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis for large-scale deletions detects <i>SOX2</i> pathogenic variants in 25%-30% of individuals, including 40% of individuals with <b>bilateral</b> anophthalmia/microphthalmia and &#x0003c;3% of individuals with <b>unilateral</b> eye involvement [<a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>, <a class="bk_pop" href="#sox2.REF.chassaing.2014.326">Chassaing et al 2014</a>, <a class="bk_pop" href="#sox2.REF.williamson.2014">Williamson &#x00026; FitzPatrick 2014</a>].</p></div></dd><dt>4. </dt><dd><div id="sox2.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="sox2.TF.1.5"><p class="no_margin">Detection frequency is 7%-10% for deletions in cases with severe microphthalmia or anophthalmia [<a class="bk_pop" href="#sox2.REF.bakrania.2007.1471">Bakrania et al 2007</a>, <a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>, <a class="bk_pop" href="#sox2.REF.schilter.2013.473">Schilter et al 2013</a>]. No duplications have been identified.</p></div></dd><dt>6. </dt><dd><div id="sox2.TF.1.6"><p class="no_margin">Large (partial- and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>) deletions. Detection frequency is 4% [<a class="bk_pop" href="#sox2.REF.bakrania.2007.1471">Bakrania et al 2007</a>].</p></div></dd></dl></div></div></div></div></div><div id="sox2.Clinical_Characteristics"><h2 id="_sox2_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sox2.Clinical_Description"><h3>Clinical Description</h3><p>A total of 114 individuals from 97 families with <i>SOX2</i>-related eye defects have been studied in detail to date [<a class="bk_pop" href="#sox2.REF.williamson.2014">Williamson &#x00026; FitzPatrick 2014</a>].</p><p><b>Bilateral anophthalmia and/or microphthalmia.</b>
<i>SOX2</i>-related eye defects are usually bilateral, severe, and apparent at birth or on routine prenatal ultrasound examination. In the 114 individuals reported to date, 56 (49%) had bilateral anophthalmia, 19 (17%) had anophthalmia with contralateral microphthalmia, and 12 (10%) had bilateral microphthalmia. The remaining individuals have a wide spectrum of eye malformations including the following [<a class="bk_pop" href="#sox2.REF.williamson.2014">Williamson &#x00026; FitzPatrick 2014</a>]:</p><ul><li class="half_rhythm"><div>Unilateral anopthalmia or microphthalmia and a normal eye</div></li><li class="half_rhythm"><div>Unilateral microphthalmia with coloboma or iris defect in the contralateral eye</div></li><li class="half_rhythm"><div>Coloboma</div></li><li class="half_rhythm"><div>Optic nerve hypoplasia</div></li><li class="half_rhythm"><div>Cataract</div></li><li class="half_rhythm"><div>Retinal dysplasia</div></li><li class="half_rhythm"><div>Anterior segment dysgenesis (including sclerocornea or microcornea)</div></li><li class="half_rhythm"><div>Refractive error</div></li></ul><p>Three individuals with <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants had bilateral structurally normal eyes. These individuals were: a monozygotic twin with tracheoesophageal fistula and unilateral reduced palpebral fissure (the other twin had anophthalmia-esophageal atresia-genital abnormalities [AEG] syndrome with unilateral anophthalmia) [<a class="bk_pop" href="#sox2.REF.zenteno.2006.1899">Zenteno et al 2006</a>]; a sibling fetus in a family with AEG syndrome, with brain anomalies and 11 rib pairs [<a class="bk_pop" href="#sox2.REF.chassaing.2007.289">Chassaing et al 2007</a>]; and a mother (with heterozygosity or a high level of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hypogonadotropic hypogonadism who, following assisted conception, had two children with bilateral anophthalmia or unilateral microphthalmia with coloboma [<a class="bk_pop" href="#sox2.REF.stark.2011.753">Stark et al 2011</a>].</p><p>The degree of visual impairment is usually severe and consistent with the degree of structural abnormality in the eye. In general, retina tissue that is present has some functional activity. For example, even in extreme microphthalmia, functional retinal tissue can give some light/dark perception with or without color perception.</p><p><b>Brain malformation.</b> Twelve children had mesial temporal (hippocampal and parahippocampal) malformations evident on MRI. Two also had evidence of heterotopic grey matter in the mesial temporal region [<a class="bk_pop" href="#sox2.REF.sisodiya.2006.534">Sisodiya et al 2006</a>]. Pituitary hypoplasia and agenesis or dysgenesis of the corpus callosum have been reported in multiple individuals [<a class="bk_pop" href="#sox2.REF.guichet.2004.828">Guichet et al 2004</a>, <a class="bk_pop" href="#sox2.REF.ragge.2005a.1008">Ragge et al 2005a</a>, <a class="bk_pop" href="#sox2.REF.zenteno.2005.564">Zenteno et al 2005</a>, <a class="bk_pop" href="#sox2.REF.hever.2006.459">Hever et al 2006</a>, <a class="bk_pop" href="#sox2.REF.kelberman.2006.2442">Kelberman et al 2006</a>, <a class="bk_pop" href="#sox2.REF.williamson.2006.1413">Williamson et al 2006</a>, <a class="bk_pop" href="#sox2.REF.bakrania.2007.1471">Bakrania et al 2007</a>, <a class="bk_pop" href="#sox2.REF.kelberman.2008.1865">Kelberman et al 2008</a>, <a class="bk_pop" href="#sox2.REF.zhou.2008.583">Zhou et al 2008</a>, <a class="bk_pop" href="#sox2.REF.schneider.2009.2706">Schneider et al 2009</a>, <a class="bk_pop" href="#sox2.REF.gonzalezrodriguez.2010.1100">Gonzalez-Rodriguez et al 2010</a>, <a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>, <a class="bk_pop" href="#sox2.REF.chassaing.2014.326">Chassaing et al 2014</a>, <a class="bk_pop" href="#sox2.REF.macchiaroli.2014.282">Macchiaroli et al 2014</a>].</p><p><b>Anterior pituitary hypoplasia.</b> The majority of cases have some evidence of hypothalamo-pituitary axis dysfunction when detailed measurement of growth hormone and gonadotrophins are undertaken [<a class="bk_pop" href="#sox2.REF.tziaferi.2008.194">Tziaferi et al 2008</a>].</p><ul><li class="half_rhythm"><div><b>Postnatal growth failure.</b> Birth weight in most infants is normal for gestational age. However, most children have a reduced growth velocity in the first years of life resulting in symmetric growth failure.</div></li><li class="half_rhythm"><div><b>Hypogonadotropic hypogonadism.</b> This feature is reported in 17 individuals, including one mother with normal eyes [<a class="bk_pop" href="#sox2.REF.stark.2011.753">Stark et al 2011</a>] and one male with unilateral retinal detachment, micropenis, and cryptorchidism [<a class="bk_pop" href="#sox2.REF.takagi.2014.133">Takagi et al 2014</a>].</div></li><li class="half_rhythm"><div><b>Genital abnormalities.</b> Micropenis, hypospadias, and cryptorchidism were frequent abnormalities in male cases, whereas hypoplastic uterus and ovarian agenesis were rare features in female cases.</div></li></ul><p><b>Delayed motor development</b> was reported in the majority of cases; the age of achieving independent walking ranged from 12 months to four years, although some individuals never achieve independent ambulation.</p><p><b>Learning disability</b> is highly variable and ranged from normal intelligence to severe learning disability, with the majority of those tested scoring between these extremes. The degree of learning disability is not predictable by mutation type or severity of the eye involvement.</p><p><b>Seizures</b> were observed in 16 individuals; onset is variable, but common in early childhood. Information on the exact seizure type is limited, but most appeared to be grand mal tonic-clonic seizures, which appeared in early childhood and responded well to standard anticonvulsant medication.</p><p><b>Sensorineural hearing loss.</b> Five children had apparently non-progressive moderate sensorineural hearing loss requiring hearing aids.</p><p><b>Esophageal atresia with or without tracheoesophageal fistula.</b> Heterozygous pathogenic variants in <i>SOX2</i> have been identified in eight unrelated individuals and monozygotic twins with AEG syndrome (OMIM <a href="http://omim.org/entry/206900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">206900</a>) [<a class="bk_pop" href="#sox2.REF.kelberman.2006.2442">Kelberman et al 2006</a>, <a class="bk_pop" href="#sox2.REF.williamson.2006.1413">Williamson et al 2006</a>, <a class="bk_pop" href="#sox2.REF.zenteno.2006.1899">Zenteno et al 2006</a>, <a class="bk_pop" href="#sox2.REF.bakrania.2007.1471">Bakrania et al 2007</a>, <a class="bk_pop" href="#sox2.REF.chassaing.2007.289">Chassaing et al 2007</a>, <a class="bk_pop" href="#sox2.REF.chassaing.2014.326">Chassaing et al 2014</a>]. AEG syndrome does not appear to be a distinct entity, but rather part of the spectrum of <i>SOX2</i>-related eye disorders.</p></div><div id="sox2.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Almost all <i>SOX2</i> pathogenic variants reported to date appear to represent <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> loss of function; thus, it is difficult to draw <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>.</p><p>Penetrance appears to be complete for non-mosaic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants. Variable expressivity is a feature observed with some pathogenic variants, such as the most common variant <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> that alters the N-terminal region polyglycine repeat [<a class="bk_pop" href="#sox2.REF.zenteno.2006.1899">Zenteno et al 2006</a>, <a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>], and the recurrent variant allele that alters a specific residue in the partner-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#sox2.REF.mihelec.2009.1417">Mihelec et al 2009</a>, <a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>].</p></div><div id="sox2.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be complete for non-mosaic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants.</p></div><div id="sox2.Nomenclature"><h3>Nomenclature</h3><p>The condition has also been called <i>SOX2</i> anophthalmia syndrome [<a class="bk_pop" href="#sox2.REF.ragge.2005b.1">Ragge et al 2005b</a>].</p><p>Microphthalmia-anophthalmia-coloboma (MAC) was used as an umbrella term for the spectrum of severe eye malformations in some early publications describing <i>SOX2</i>-related eye disorders. This may be an inappropriate acronym as it implies that coloboma is an intrinsic part of all microphthalmia, which no longer appears to be the case.</p><p>Each of the hypothetic explanations for the embryonic origin of the small or missing eyes associated with <i>SOX2</i> pathogenic variants predicts a different spectrum of clinical phenotypes.</p><ul><li class="half_rhythm"><div>If the primary defect were in the mechanism of optic fissure closure, the predicted order of severity would be iris coloboma, choroidal/retinal coloboma, microphthalmia with coloboma or orbital cyst, and anophthalmia.</div></li><li class="half_rhythm"><div>If lens induction were impaired, the predicted clinical spectrum would be <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataract &#x0003e; microphthalmia &#x0003e; anophthalmia.</div></li><li class="half_rhythm"><div>If the main effects of <i>SOX2</i> were in retinal differentiation, the predicted clinical manifestations would be retinal dystrophy &#x0003e; microphthalmia.</div></li><li class="half_rhythm"><div>It is also possible that complete failure of optic vesicle formation results in anophthalmia without optic nerve formation.</div></li></ul><p>Thus, the term MAC has inadequate descriptive power to be useful. The particular spectrum associated with <i>SOX2</i>-related eye disorders is not yet clear because most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have very small or absent eyes, which are thus morphologically unclassifiable. Coloboma has been reported but is not a common feature.</p><p>Anophthalmia-esophageal atresia-genital abnormalities (AEG) syndrome was previously reported to be a distinct disorder, but is now known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>SOX2</i> in some individuals [<a class="bk_pop" href="#sox2.REF.williamson.2006.1413">Williamson et al 2006</a>, <a class="bk_pop" href="#sox2.REF.zenteno.2006.1899">Zenteno et al 2006</a>]; thus, it appears that esophageal atresia with or without tracheoesophageal fistula is a feature of <i>SOX2</i>-related eye disorders and not a separate condition. This is consistent with the known expression of <i>SOX2</i> in the endoderm and genital ridge during development of chick and mouse embryos.</p></div><div id="sox2.Prevalence"><h3>Prevalence</h3><p>Prevalence is approximately 1:250,000 (UK estimate) [Author, personal data].</p></div></div><div id="sox2.Genetically_Related_Allelic_Disorde"><h2 id="_sox2_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>SOX2</i>.</p></div><div id="sox2.Differential_Diagnosis"><h2 id="_sox2_Differential_Diagnosis_">Differential Diagnosis</h2><p><i>SOX2</i> pathogenic variants account for 40% of bilateral anophthalmia, making it the most frequent known genetic cause of severe bilateral eye malformations. However, these disorders show marked etiologic heterogeneity.</p><p><i>OTX2</i> anophthalmia syndrome (OMIM <a href="http://omim.org/entry/610125" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610125</a>), caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>OTX2</i>, can present with almost identical ocular and brain features to <i>SOX2</i> anophthalmia syndrome [<a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>]. However, esophageal atresia and tracheoesophageal fistula have not been described in association with mutation of <i>OTX2</i>.</p><p><a href="/books/n/gene/charge/">CHARGE syndrome</a> should be considered in children with ocular malformations, growth deficiency, micropenis, and tracheaesophageal fistula. Sequence analysis of <i>CHD7</i> in individuals with either typical CHARGE syndrome or a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., fewer major characteristics) detects pathogenic variants in approximately 65%-70% of cases. In one individual with AEG syndrome in whom no <i>SOX2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variant in <i>CHD7</i> has subsequently been identified [Williamson &#x00026; FitzPatrick, unpublished].</p><p>One rather poorly defined condition that may resemble <i>SOX2</i>-related eye disorders is Lenz microphthalmia syndrome (LMS), characterized by unilateral or bilateral microphthalmia and/or anophthalmia with malformations of the ears, teeth, fingers, skeleton, or genitourinary system. Approximately 60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have mild-to-severe intellectual disability or developmental delay. Two loci on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a>, MCOPS1 and MCOPS2, are known to be associated with LMS. The LMS-associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> on MCOPS2 is <i>BCOR</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</p><p>Pathogenic variants in <i>CHX10, RAX, PAX6</i> (see <a href="/books/n/gene/aniridia/">Aniridia</a>), and <i>OTX2</i> can have overlapping phenotypes.</p><p>See <a href="/books/n/gene/tef-ov/">Esophageal Atresia/Tracheoesophageal Fistula Overview</a> for a more complete differential diagnosis.</p></div><div id="sox2.Management"><h2 id="_sox2_Management_">Management</h2><div id="sox2.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>SOX2</i>-related eye disorder, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Examination by an experienced pediatric ophthalmologist</div></li><li class="half_rhythm"><div>High-resolution cranial MRI for brain/pituitary malformations, optic nerve/chiasm/tract assessment</div></li><li class="half_rhythm"><div>Endocrinologic evaluation to include corticosteroid, gonadotrphin, growth hormone, and thyroid function tests to assess pituitary function</div></li><li class="half_rhythm"><div>Baseline neurodevelopmental assessment</div></li><li class="half_rhythm"><div>Audiometry</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sox2.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Visual impairment.</b> The general management of visual impairment is not specific to anophthalmia or microphthalmia. Care includes:</p><ul><li class="half_rhythm"><div>Early referral to an experienced multidisciplinary team</div></li><li class="half_rhythm"><div>Consideration of use of expanders to stimulate growth of the orbit and periorbital tissues. Because accurate assessment of visual function is necessary, optically clear expanders should be used.</div></li><li class="half_rhythm"><div>Referral to special educational services for visually impaired infants</div></li></ul><p><b>Other</b></p><ul><li class="half_rhythm"><div>Referral to endocrinologist for growth or hypogonadism concerns</div></li><li class="half_rhythm"><div>Referral to physiotherapist if any evidence of motor impairment exists</div></li><li class="half_rhythm"><div>Referral to special educational services for neurodevelopmental problems as needed</div></li><li class="half_rhythm"><div>Consideration of use of melatonin for regulation of circadian rhythm if sleep pattern is abnormal</div></li><li class="half_rhythm"><div>Parent/caregiver training in seizure management</div></li></ul></div><div id="sox2.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Many neonates can have an adequate MRI without general anesthesia using the "feed and wrap" method. In this case, assess morning cortisol levels prior to any subsequent anesthetic if this MRI reveals pituitary hypoplasia. If an anesthetic is required before adequate intracranial imaging is available, an endocrinologic evaluation is indicated.</p></div><div id="sox2.Surveillance"><h3>Surveillance</h3><p>The following measures are suggested:</p><ul><li class="half_rhythm"><div>Annual hearing test</div></li><li class="half_rhythm"><div>Measurement of height, weight, and head circumference every three to six months during childhood</div></li><li class="half_rhythm"><div>Neurodevelopmental assessment annually for the first five years of life</div></li></ul></div><div id="sox2.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sox2.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sox2.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sox2.Genetic_Counseling"><h2 id="_sox2_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sox2.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>SOX2</i>-related eye disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, most often resulting from a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Rarely, parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> can result in a "pseudo-<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>" pattern of inheritance [<a class="bk_pop" href="#sox2.REF.faivre.2006.636">Faivre et al 2006</a>, <a class="bk_pop" href="#sox2.REF.schneider.2008.2794">Schneider et al 2008</a>, <a class="bk_pop" href="#sox2.REF.zhou.2008.583">Zhou et al 2008</a>, <a class="bk_pop" href="#sox2.REF.schneider.2009.2706">Schneider et al 2009</a>].</p></div><div id="sox2.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>SOX2</i>-related eye disorder most often has the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In such cases, both parents are unaffected and do not have a <i>SOX2</i> pathogenic variant. The proportion of cases known to be caused by a <i>de novo</i> pathogenic variant is 60%.</div></li><li class="half_rhythm"><div class="half_rhythm">Autosomal dominant transmission has been reported.</div><ul><li class="half_rhythm"><div>One individual diagnosed with unilateral anophthalmia had a similarly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother [<a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>].</div></li><li class="half_rhythm"><div>Maternal transmission of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was observed in a four-generation family with eye defects ranging from microcornea or retinal tuft with refractive error to bilateral anophthalmia [<a class="bk_pop" href="#sox2.REF.mihelec.2009.1417">Mihelec et al 2009</a>], and in a mother and child with bilateral coloboma and bilateral anopthalmia/microphthalmia with coloboma, respectively [<a class="bk_pop" href="#sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</a>].</div></li><li class="half_rhythm"><div>A mother with a <i>SOX2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hypogonadotropic hypogonadism had two affected children: a son with bilateral anophthalmia and subtle endocrine abnormalities and a daughter with unilateral microphthalmia with coloboma [<a class="bk_pop" href="#sox2.REF.stark.2011.753">Stark et al 2011</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has been reported.</div><div class="half_rhythm">Phenotypically normal parents may have <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div><ul><li class="half_rhythm"><div>Recurrence of anophthalmia and/or microphthalmia has been reported in four families in which the phenotypically normal mother had <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> that was either detected [<a class="bk_pop" href="#sox2.REF.faivre.2006.636">Faivre et al 2006</a>, <a class="bk_pop" href="#sox2.REF.schneider.2008.2794">Schneider et al 2008</a>, <a class="bk_pop" href="#sox2.REF.zhou.2008.583">Zhou et al 2008</a>, <a class="bk_pop" href="#sox2.REF.schneider.2009.2706">Schneider et al 2009</a>] or was probable but undetected [<a class="bk_pop" href="#sox2.REF.schneider.2009.2706">Schneider et al 2009</a>].</div></li><li class="half_rhythm"><div>Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> was identified in the mother of two sibs, both with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and bilateral anophthalmia or normal eyes [<a class="bk_pop" href="#sox2.REF.chassaing.2007.289">Chassaing et al 2007</a>, <a class="bk_pop" href="#sox2.REF.chassaing.2014.326">Chassaing et al 2014</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include detailed ophthalmologic examination of the parents and, if the pathogenic variant in the proband has been identified, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of DNA ideally extracted from more than one tissue source (e.g., leukocytes and buccal cells).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p><ul><li class="half_rhythm"><div>Because <i>SOX2</i>-related eye disorders typically occur as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is usually small.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <i>SOX2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the <i>SOX2</i> pathogenic variant is 50%.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, the risk to the sibs of inheriting the <i>SOX2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may be up to 50%.</div></li><li class="half_rhythm"><div>The incidence of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for <i>SOX2</i>-related eye disorders is approximately 6%. Germline mosaicism can result in a "pseudo-<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>" pattern of inheritance [<a class="bk_pop" href="#sox2.REF.faivre.2006.636">Faivre et al 2006</a>, <a class="bk_pop" href="#sox2.REF.schneider.2008.2794">Schneider et al 2008</a>, <a class="bk_pop" href="#sox2.REF.zhou.2008.583">Zhou et al 2008</a>, <a class="bk_pop" href="#sox2.REF.schneider.2009.2706">Schneider et al 2009</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a <i>SOX2</i>-related eye disorder has a 50% chance of inheriting the <i>SOX2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Because the majority of <i>SOX2</i>-related eye disorders occur as the result of a fully penetrant <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, unaffected family members other than parents of a proband are not at increased risk. Variable expressivity can result in relatively mild phenotypes in rare cases.</p></div><div id="sox2.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or clinical evidence of the disorder, the <i>SOX2</i> pathogenic variant is likely <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sox2.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>SOX2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for a <i>SOX2</i>-related eye disorder are possible. However, severity of disease and specific clinical findings are variable and cannot be accurately predicted by the family history or results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Fetal ultrasound examination/fetal MRI</b> is also possible as the eye malformations in fetuses with <i>SOX2</i>-related eye disorders (bilateral anophthalmia or severe microphthalmia) are usually severe and can be detected during the second trimester of pregnancy using fetal ultrasound.</p></div></div><div id="sox2.Resources"><h2 id="_sox2_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>International Children's Anophthalmia and Microphthalmia Network (ICAN)</b></div><div>c/o Center for Developmental Medicine and Genetics</div><div>5501 Old York Road</div><div>Genetics, Levy 2 West</div><div>Philadelphia PA 19141</div><div><b>Phone:</b> 800-580-4226 (toll-free)</div><div><b>Email:</b> ican@anophthalmia.org</div><div><a href="http://www.anophthalmia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.anophthalmia.org</a></div></li><li class="half_rhythm"><div><b>The Micro and Anophthalmic Children&#x02019;s Society</b></div><div>Kemp House, 152 City Road</div><div>Suite 472</div><div>London EC1V 2NX</div><div>United Kingdom</div><div><b>Phone:</b> 0800 169 8088</div><div><b>Email:</b> enquiries@macs.org.uk</div><div><a href="http://www.macs.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.macs.org.uk/</a></div></li><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/low-vision" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low Vision</a></div></li><li class="half_rhythm"><div><b>National Federation of the Blind (NFB)</b></div><div>200 East Wells Street</div><div>(at Jernigan Place)</div><div>Baltimore MD 21230</div><div><b>Phone:</b> 410-659-9314</div><div><b>Fax:</b> 410-685-5653</div><div><b>Email:</b> pmaurer@nfb.org</div><div><a href="http://www.nfb.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nfb.org</a></div></li></ul></div><div id="sox2.Molecular_Genetics"><h2 id="_sox2_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sox2.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SOX2-Related Eye Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1300/table/sox2.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sox2.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sox2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sox2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sox2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sox2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_sox2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sox2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sox2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6657" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SOX2</i></a></td><td headers="hd_b_sox2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6657" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q26<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_sox2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P48431" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transcription factor SOX-2</a></td><td headers="hd_b_sox2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://lsdb.hgu.mrc.ac.uk/home.php?select_db=SOX2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOX2 @ The Human Genetics Unit Edinburgh U.K.</a></td><td headers="hd_b_sox2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SOX2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOX2</a></td><td headers="hd_b_sox2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SOX2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOX2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sox2.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sox2.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SOX2-Related Eye Disorders (<a href="/omim/184429,206900" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1300/table/sox2.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sox2.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/184429" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">184429</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SRY-BOX 2; SOX2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/206900" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">206900</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MICROPHTHALMIA, SYNDROMIC 3; MCOPS3</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> comprises one <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1300/#sox2.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> The NHLBI Exome Sequencing Project <a href="http://evs.gs.washington.edu/EVS/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Exome Variant Server</a>
<a href="http://evs.gs.washington.edu/EVS/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://evs.gs.washington.edu/EVS/</a>(accessed 6-14) lists seven benign variants that do not alter the primary protein sequence, and seven variants that are likely benign or of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a> and that are predicted to substitute residues in the transactivation <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of SOX-2. There are no variants of these types known to affect the HMG domain or the partner-binding domain. The <i>SOX</i> genes are defined as having greater than 60% homology within the HMG domain to human <i>SRY</i>. Within the <i>SOX</i> family, <i>SOX2</i> belongs to the <i>SOXB</i> subgroup with <i>SOX1</i>, <i>SOX3</i>, <i>SOX14</i>, and <i>SOX21</i>.</p><p><b>Pathogenic variants.</b> All <i>SOX2</i> pathogenic variants identified to date result in apparent loss of function. The most common variant types are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift. Five alleles, predicted to frameshift the codons of an N-terminal region polyglycine repeat, account for almost one fifth of the pathogenic variants in individuals and families. The remaining known pathogenic variants are nonsynonymous, <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>, and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> alleles. Details of all the known pathogenic variants are available in an online <a href="http://lsdb.hgu.mrc.ac.uk/home.php?select_db=SOX2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>SOX2</i> mutation database</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Transcription factor SOX-2 is a 317-amino acid peptide. It has an HMG DNA-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (amino acids 40-111), a partner-binding domain and a C-terminal transactivation domain. The N-terminal region is of unknown function and contains short polyglycine and polyalanine repeats.</p><p><i>SOX2</i> is expressed in mouse embryonic stem cells and has been shown to act as part of a transcriptional activator complex for several important developmental genes [<a class="bk_pop" href="#sox2.REF.ambrosetti.2000.23387">Ambrosetti et al 2000</a>, <a class="bk_pop" href="#sox2.REF.tomioka.2002.3202">Tomioka et al 2002</a>] including other genes known to be critical to eye development (e.g., <i>PAX6</i> and <i>MAF1</i>) [<a class="bk_pop" href="#sox2.REF.kamachi.2001.1272">Kamachi et al 2001</a>, <a class="bk_pop" href="#sox2.REF.muta.2002.791">Muta et al 2002</a>]. It is an early marker of neurulation in chick embryos and shows site- and stage-specific expression in the developing nervous system, genital ridge, and foregut in all vertebrates studied.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> As <i>SOX2</i> is a single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> gene, it is not subject to <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated decay and it is possible that truncated peptide may be produced in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. If these abnormal peptides were stable, they could have a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect. However, with the increase in the number of variant alleles known, differences between the clinical features of those with whole-gene deletions and those with stop gain pathogenic variants are not evident, suggesting that there is no dominant-negative effect.</p><p>Two thirds of the <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants that have been identified are within the highly conserved HMG DNA-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Functional studies on two of these variants, using a modified yeast one-hybrid system, confirm that these pathogenic variants severely diminish the activation of DC5 delta crystalline enhancer through loss of cooperative <i>SOX2</i>/<i>PAX6</i> binding [<a class="bk_pop" href="#sox2.REF.williamson.2006.1413">Williamson et al 2006</a>].</p></div><div id="sox2.References"><h2 id="_sox2_References_">References</h2><div id="sox2.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.ambrosetti.2000.23387">Ambrosetti DC, Scholer HR, Dailey L, Basilico C. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:23387–97.</span> [<a href="/pubmed/10801796" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10801796</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.bakrania.2007.1471">Bakrania P, Robinson DO, Bunyan DJ, Salt A, Martin A, Crolla JA, Wyatt A, Fielder A, Ainsworth J, Moore A, Read S, Uddin J, Laws D, Pascuel-Salcedo D, Ayuso C, Allen L, Collin JR, Ragge NK. SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions. <span><span class="ref-journal">Br J Ophthalmol. </span>2007;<span class="ref-vol">91</span>:1471–6.</span> [<a href="/pmc/articles/PMC2095460/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2095460</span></a>] [<a href="/pubmed/17522144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17522144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.chassaing.2014.326">Chassaing N, Causse A, Vigouroux A, Delahaye A, Alessandri JL, Boespflug-Tanguy O, Boute-Benejean O, Dollfus H, Duban-Bedu B, Gilbert-Dussardier B, Giuliano F, Gonzales M, Holder-Espinasse M, Isidor B, Jacquemont ML, Lacombe D, Martin-Coignard D, Mathieu-Dramard M, Odent S, Picone O, Pinson L, Quelin C, Sigaudy S, Toutain A, Thauvin-Robinet C, Kaplan J, Calvas P. Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia. <span><span class="ref-journal">Clin Genet. </span>2014;<span class="ref-vol">86</span>:326–34.</span> [<a href="/pubmed/24033328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24033328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.chassaing.2007.289">Chassaing N, Gilbert-Dussardier B, Nicot F, Fermeaux V, Encha-Razavi F, Fiorenza M, Toutain A, Calvas P. Germinal mosaicism and familial recurrence of a SOX2 mutation with highly variable phenotypic expression extending from AEG syndrome to absence of ocular involvement. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:289–91.</span> [<a href="/pubmed/17219395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17219395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.faivre.2006.636">Faivre L, Williamson KA, Faber V, Laurent N, Grimaldi M, Thauvin-Robinet C, Durand C, Mugneret F, Gouyon JB, Bron A, Huet F, Hayward C, Heyningen VV, Fitzpatrick DR. Recurrence of SOX2 anophthalmia syndrome with gonosomal mosaicism in a phenotypically normal mother. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:636–9.</span> [<a href="/pubmed/16470798" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16470798</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.fantes.2003.461">Fantes J, Ragge NK, Lynch SA, McGill NI, Collin JR, Howard-Peebles PN, Hayward C, Vivian AJ, Williamson K, van Heyningen V, FitzPatrick DR. Mutations in SOX2 cause anophthalmia. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:461–3.</span> [<a href="/pubmed/12612584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12612584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert C, Williamson K, Ansari M, Rainger JK, Hingst V, Zimmermann T, Tech S, Guthoff RF, van Heyningen V, Fitzpatrick DR. Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2013;<span class="ref-vol">1</span>:15–31.</span> [<a href="/pmc/articles/PMC3893155/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3893155</span></a>] [<a href="/pubmed/24498598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24498598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.gonzalezrodriguez.2010.1100">Gonzalez-Rodriguez J, Pelcastre EL, Tovilla-Canales JL, Garcia-Ortiz JE, Amato-Almanza M, Villanueva-Mendoza C, Espinosa-Mattar Z, Zenteno JC. Mutational screening of CHX10, GDF6, OTX2, RAX and SOX2 genes in 50 unrelated microphthalmia-anophthalmia-coloboma (MAC) spectrum cases. <span><span class="ref-journal">Br J Ophthalmol. </span>2010;<span class="ref-vol">94</span>:1100–4.</span> [<a href="/pubmed/20494911" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20494911</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.guichet.2004.828">Guichet A, Triau S, Lepinard C, Esculapavit C, Biquard F, Descamps P, Encha-Razavi F, Bonneau D. Prenatal diagnosis of primary anophthalmia with a 3q27 interstitial deletion involving SOX2. <span><span class="ref-journal">Prenat Diagn. </span>2004;<span class="ref-vol">24</span>:828–32.</span> [<a href="/pubmed/15503273" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15503273</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.hever.2006.459">Hever AM, Williamson KA, van Heyningen V. Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2. <span><span class="ref-journal">Clin Genet. </span>2006;<span class="ref-vol">69</span>:459–70.</span> [<a href="/pubmed/16712695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16712695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.kamachi.2001.1272">Kamachi Y, Uchikawa M, Tanouchi A, Sekido R, Kondoh H. Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development. <span><span class="ref-journal">Genes Dev. </span>2001;<span class="ref-vol">15</span>:1272–86.</span> [<a href="/pmc/articles/PMC313803/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC313803</span></a>] [<a href="/pubmed/11358870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11358870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.kelberman.2008.1865">Kelberman D, de Castro SC, Huang S, Crolla JA, Palmer R, Gregory JW, Taylor D, Cavallo L, Faienza MF, Fischetto R, Achermann JC, Martinez-Barbera JP, Rizzoti K, Lovell-Badge R, Robinson IC, Gerrelli D, Dattani MT. SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2008;<span class="ref-vol">93</span>:1865–73.</span> [<a href="/pmc/articles/PMC3479085/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3479085</span></a>] [<a href="/pubmed/18285410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18285410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.kelberman.2006.2442">Kelberman D, Rizzoti K, Avilion A, Bitner-Glindzicz M, Cianfarani S, Collins J, Chong WK, Kirk JM, Achermann JC, Ross R, Carmignac D, Lovell-Badge R, Robinson IC, Dattani MT. Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. <span><span class="ref-journal">J Clin Invest. </span>2006;<span class="ref-vol">116</span>:2442–55.</span> [<a href="/pmc/articles/PMC1551933/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1551933</span></a>] [<a href="/pubmed/16932809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16932809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.kurbasic.2000.239">Kurbasic M, Jones FV, Cook LN. Bilateral microphthalmos with colobomatous orbital cyst and de-novo balanced translocation t(3;5). <span><span class="ref-journal">Ophthalmic Genet. </span>2000;<span class="ref-vol">21</span>:239–42.</span> [<a href="/pubmed/11135495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11135495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.macchiaroli.2014.282">Macchiaroli A, Kelberman D, Auriemma RS, Drury S, Islam L, Giangiobbe S, Ironi G, Lench N, Sowden JC, Colao A, Pivonello R, Cavallo L, Gasperi M, Faienza MF. A novel heterozygous SOX2 mutation causing congenital bilateral anophthalmia, hypogonadotropic hypogonadism and growth hormone deficiency. <span><span class="ref-journal">Gene. </span>2014;<span class="ref-vol">534</span>:282–5.</span> [<a href="/pubmed/24211324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24211324</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.male.2002.807">Male A, Davies A, Bergbaum A, Keeling J, FitzPatrick D, Mackie Ogilvie C, Berg J. Delineation of an estimated 6.7 MB candidate interval for an anophthalmia gene at 3q26.33-q28 and description of the syndrome associated with visible chromosome deletions of this region. <span><span class="ref-journal">Eur J Hum Genet. </span>2002;<span class="ref-vol">10</span>:807–12.</span> [<a href="/pubmed/12461687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12461687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.mihelec.2009.1417">Mihelec M, Abraham P, Gibson K, Krowka R, Susman R, Storen R, Chen Y, Donald J, Tam PP, Grigg JR, Flaherty M, Gole GA, Jamieson RV. Novel SOX2 partner-factor domain mutation in a four-generation family. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:1417–22.</span> [<a href="/pmc/articles/PMC2986670/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986670</span></a>] [<a href="/pubmed/19471311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19471311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.muta.2002.791">Muta M, Kamachi Y, Yoshimoto A, Higashi Y, Kondoh H. Distinct roles of SOX2, Pax6 and Maf transcription factors in the regulation of lens-specific delta1-crystallin enhancer. <span><span class="ref-journal">Genes Cells. </span>2002;<span class="ref-vol">7</span>:791–805.</span> [<a href="/pubmed/12167158" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12167158</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.ragge.2005a.1008">Ragge NK, Brown AG, Poloschek CM, Lorenz B, Henderson RA, Clarke MP, Russell-Eggitt I, Fielder A, Gerrelli D, Martinez-Barbera JP, Ruddle P, Hurst J, Collin JR, Salt A, Cooper ST, Thompson PJ, Sisodiya SM, Williamson KA, Fitzpatrick DR, van Heyningen V, Hanson IM. Heterozygous mutations of OTX2 cause severe ocular malformations. <span><span class="ref-journal">Am J Hum Genet. </span>2005a;<span class="ref-vol">76</span>:1008–22.</span> [<a href="/pmc/articles/PMC1196439/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196439</span></a>] [<a href="/pubmed/15846561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15846561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.ragge.2005b.1">Ragge NK, Lorenz B, Schneider A, Bushby K, de Sanctis L, de Sanctis U, Salt A, Collin JR, Vivian AJ, Free SL, Thompson P, Williamson KA, Sisodiya SM, van Heyningen V, Fitzpatrick DR. SOX2 anophthalmia syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2005b;<span class="ref-vol">135</span>:1–7.</span> [<a href="/pubmed/15812812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15812812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.schilter.2013.473">Schilter KF, Reis LM, Schneider A, Bardakjian TM, Abdul-Rahman O, Kozel BA, Zimmerman HH, Broeckel U, Semina EV. Whole-genome copy number variation analysis in anophthalmia and microphthalmia. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">84</span>:473–81.</span> [<a href="/pmc/articles/PMC3985344/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3985344</span></a>] [<a href="/pubmed/23701296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23701296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.schneider.2009.2706">Schneider A, Bardakjian T, Reis LM, Tyler RC, Semina EV. Novel SOX2 mutations and genotype-phenotype correlation in anophthalmia and microphthalmia. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:2706–15.</span> [<a href="/pmc/articles/PMC2787970/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2787970</span></a>] [<a href="/pubmed/19921648" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19921648</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.schneider.2008.2794">Schneider A, Bardakjian TM, Zhou J, Hughes N, Keep R, Dorsainville D, Kherani F, Katowitz J, Schimmenti LA, Hummel M, Fitzpatrick DR, Young TL. Familial recurrence of SOX2 anophthalmia syndrome: phenotypically normal mother with two affected daughters. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2794–8.</span> [<a href="/pmc/articles/PMC3693575/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3693575</span></a>] [<a href="/pubmed/18831064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18831064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.sisodiya.2006.534">Sisodiya SM, Ragge NK, Cavalleri GL, Hever A, Lorenz B, Schneider A, Williamson KA, Stevens JM, Free SL, Thompson PJ, van Heyningen V, Fitzpatrick DR. Role of SOX2 mutations in human hippocampal malformations and epilepsy. <span><span class="ref-journal">Epilepsia. </span>2006;<span class="ref-vol">47</span>:534–42.</span> [<a href="/pubmed/16529618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16529618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.stark.2011.753">Stark Z, Storen R, Bennetts B, Savarirayan R, Jamieson RV. Isolated hypogonadotropic hypogonadism with SOX2 mutation and anophthalmia/microphthalmia in offspring. <span><span class="ref-journal">Eur J Hum Genet. </span>2011;<span class="ref-vol">19</span>:753–6.</span> [<a href="/pmc/articles/PMC3137491/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3137491</span></a>] [<a href="/pubmed/21326281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21326281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.takagi.2014.133">Takagi M, Narumi S, Asakura Y, Muroya K, Hasegawa Y, Adachi M, Hasegawa T. A novel mutation in SOX2 causes hypogonadotropic hypogonadism with mild ocular malformation. <span><span class="ref-journal">Horm Res Paediatr. </span>2014;<span class="ref-vol">81</span>:133–8.</span> [<a href="/pubmed/24457197" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24457197</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.tomioka.2002.3202">Tomioka M, Nishimoto M, Miyagi S, Katayanagi T, Fukui N, Niwa H, Muramatsu M, Okuda A. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. <span><span class="ref-journal">Nucleic Acids Res. </span>2002;<span class="ref-vol">30</span>:3202–13.</span> [<a href="/pmc/articles/PMC135755/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC135755</span></a>] [<a href="/pubmed/12136102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12136102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.tziaferi.2008.194">Tziaferi V, Kelberman D, Dattani MT. The role of SOX2 in hypogonadotropic hypogonadism. <span><span class="ref-journal">Sex Dev. </span>2008;<span class="ref-vol">2</span>:194–9.</span> [<a href="/pubmed/18987493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18987493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.williamson.2014">Williamson KA, FitzPatrick DR. The genetic architecture of microphthalmia, anophthalmia and coloboma. Eur J Med Genet. 2014 May 22. pii: S1769-7212(14)00114-1.</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.williamson.2006.1413">Williamson KA, Hever AM, Rainger J, Rogers RC, Magee A, Fiedler Z, Keng WT, Sharkey FH, McGill N, Hill CJ, Schneider A, Messina M, Turnpenny PD, Fantes JA, van Heyningen V, FitzPatrick DR. Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2006;<span class="ref-vol">15</span>:1413–22.</span> [<a href="/pubmed/16543359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16543359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.zenteno.2005.564">Zenteno JC, Gascon-Guzman G, Tovilla-Canales JL. Bilateral anophthalmia and brain malformations caused by a 20-bp deletion in the SOX2 gene. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">68</span>:564–6.</span> [<a href="/pubmed/16283891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16283891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.zenteno.2006.1899">Zenteno JC, Perez-Cano HJ, Aguinaga M. Anophthalmia-esophageal atresia syndrome caused by an SOX2 gene deletion in monozygotic twin brothers with markedly discordant phenotypes. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1899–903.</span> [<a href="/pubmed/16892407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16892407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sox2.REF.zhou.2008.583">Zhou J, Kherani F, Bardakjian TM, Katowitz J, Hughes N, Schimmenti LA, Schneider A, Young TL. Identification of novel mutations and sequence variants in the SOX2 and CHX10 genes in patients with anophthalmia/microphthalmia. <span><span class="ref-journal">Mol Vis. </span>2008;<span class="ref-vol">14</span>:583–92.</span> [<a href="/pmc/articles/PMC2275209/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2275209</span></a>] [<a href="/pubmed/18385794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18385794</span></a>]</div></li></ul></div></div><div id="sox2.Chapter_Notes"><h2 id="_sox2_Chapter_Notes_">Chapter Notes</h2><div id="sox2.Acknowledgments"><h3>Acknowledgments</h3><p>Professor Veronica van Heyningen for continued helpful collaboration</p><p>MACS family support organization for their interest and support</p></div><div id="sox2.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>31 July 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 August 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 March 2008 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis available clinically</div></li><li class="half_rhythm"><div>5 December 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>23 February 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>14 April 2005 (drf) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1300</span><span class="label">PMID: <a href="/pubmed/20301477" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301477</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sost/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hsn1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1300&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1300/?report=reader">PubReader</a></li><li><a href="/books/NBK1300/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1300" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1300" style="display:none" title="Cite this Page"><div class="bk_tt">Williamson KA, FitzPatrick DR. SOX2-Related Eye Disorders. 2006 Feb 23 [Updated 2014 Jul 31]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1300/pdf/Bookshelf_NBK1300.pdf">PDF version of this page</a> (439K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sox2.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sox2.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#sox2.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sox2.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sox2.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sox2.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sox2.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sox2.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sox2.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sox2.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sox2.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sox2.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4990[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SIX6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6657[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SOX2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1484754" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1484754" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1484754" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1484754" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301534" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moosajee M, Hingorani M, Moore AT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30896913" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RERE</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RERE</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Scott DA, Sherr EH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301487" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Smith ACM, Boyd KE, Brennan C, Charles J, Elsea SH, Finucane BM, Foster R, Gropman A, Girirajan S, Haas-Givler B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301296" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CHARGE Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CHARGE Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lalani SR, Hefner MA, Belmont JW, Davenport SLH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301694" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lenz Microphthalmia Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lenz Microphthalmia Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ng D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301477" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301477" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04148a39a66ee2bade7139">SOX2-Related Eye Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SOX2-Related Eye Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:01:47-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89B1E7E0403A510000000008230393&amp;ncbi_session=CE89B1E7E04148A1_2083SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1300%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1300&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1300/&amp;ncbi_pagename=SOX2-Related Eye Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89B1E7E04148A1_2083SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>